// App-Quantinova.ai

: Long-term efficacy and safety of intra-articular sprifermin in patients with knee osteoarthritis: results from the 5-year forward study

Researchers

Presenter

  • F. Eckstein

Principal Investigators

  • M. Hochberg

  • J. Kraines

  • H. Guehring

  • F. Moreau

  • V. Ona

  • A.R. Bihlet

  • I. Byrjalsen

  • J.R. Andersen

  • B. Daelken

  • O. Guenther

  • C. Ladel

  • M. Michaelis

  • P.G. Conaghan

Medical Centers

  • Paracelsus Med. Univ., Salzburg, Austria

  • Chondrometrics GmbH, Ainring, Germany

  • Univ of Maryland, Baltimore, MD, USA

  • EMD Serono Res. and Dev. Inst., Inc. (an affiliate of Merck KGaA), Billerica, Darmstadt, MA, Germany

  • Merck KGaA, Darmstadt, Germany

  • Nordic Bioscience, Herlev, Denmark

  • University of Leeds, Leeds, United Kingdom

Locations

  • Austria

  • Germany

  • United States

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Knee osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • Sprifermin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved